Latest Breaking News On - Monica gostissa - Page 1 : comparemela.com

John Cox gets new biotech CEO gig, jumping to Dyne—Chutes & Ladders

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer

Taconic Biosciences Expands Scientific Advisory Board

Taconic Biosciences announces Monica Gostissa, PhD, has joined its Scientific Advisory Board (SAB).

Taconic Biosciences Expands Scientific Advisory Board - News Makers

Taconic Biosciences Expands Scientific Advisory Board Dr. Monica Gostissa Joins Taconic Biosciences’ Scientific Advisory Board RENSSELAER, N.Y., March 15, 2021 (GLOBE NEWSWIRE) Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces Monica Gostissa, PhD, has joined its Scientific Advisory Board (SAB). Dr. Gostissa joins existing board members, Frank Sistare, PhD; Andrew Goodman, PhD; David Hill, PhD; and Robert Rosenthal, PhD. The SAB collaborates with Taconic management, providing scientific insight and guidance to expand the company’s product and service portfolio. Dr. Gostissa’s extensive career in the immunology and immuno-oncology fields brings new expertise to the board and complements Taconic’s leadership in these research areas.

Taconic Biosciences Expands Scientific Advisory Board | Comunicados | Edición USA

Dr. Monica Gostissa Joins Taconic Biosciences’ Scientific Advisory Board RENSSELAER, N.Y., March 15, 2021 (GLOBE NEWSWIRE) Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces Monica Gostissa, PhD, has joined its Scientific Advisory Board (SAB). Dr. Gostissa joins existing board members, Frank Sistare, PhD; Andrew Goodman, PhD; David Hill, PhD; and Robert Rosenthal, PhD. The SAB collaborates with Taconic management, providing scientific insight and guidance to expand the company’s product and service portfolio. Dr. Gostissa s extensive career in the immunology and immuno-oncology fields brings new expertise to the board and complements Taconic’s leadership in these research areas.